| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996339116203316 |
|
|
Autore |
Cazzola M |
|
|
Titolo |
Acute Exacerbations in COPD [[electronic resource]] |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford, : Atlas Medical Publishing Ltd, 2009 |
|
|
|
|
|
|
|
ISBN |
|
1-282-25517-7 |
9786612255175 |
1-84692-581-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (235 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Lungs -- Diseases, Obstructive -- Alternative treatment |
Lungs -- Diseases, Obstructive -- Diagnosis |
Lungs -- Diseases, Obstructive |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Editors; Contributors; Chapter 1: COPD exacerbations: definitions and classifications; Chapter 2: Infectious aetiologies in acute exacerbations of COPD; Chapter 3: Pathophysiology of COPD exacerbations; Chapter 4: Acute respiratory failure during exacerbation of COPD; Chapter 5: Effects of acute exacerbations on nutritional and metabolic profile in patients with COPD; Chapter 6: Outcomes in exacerbations of COPD; Chapter 7: Antibiotics in the treatment of acute exacerbations of COPD; Chapter 8: Antibiotics in COPD: pharmacokinetic/ pharmacodynamic dosing concepts |
Chapter 9: Acute exacerbations of COPD: application of evidence-based guidelinesChapter 10: Economic evaluation of antibiotic treatment of exacerbations of COPD; Chapter 11: Managing acute exacerbations in COPD with bronchodilators and corticosteroids; Chapter 12: Non-invasive positive pressure ventilation for the treatment of respiratory failure due to exacerbations of COPD; Chapter 13: 'Home hospitals' for acute exacerbations of COPD; Chapter 14: Prevention of acute exacerbations of COPD; Chapter 15: Novel therapeutic targets for acute COPD exacerbation; Abbreviations; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The pronounced variability in the incidence and severity of chronic respiratory diseases such as asthma and COPD, makes effective |
|
|
|
|
|
|
|
|
|
|
treatment more difficult, and the social and economic costs of these diseases all the greater. Acute exacerbations are multi-factorial in origin, and are known to be linked with a number of agents including allergens, atmospheric pollution and infectious agents. Effective treatment requires a similarly complex approach that addresses each of the component causes. This text brings together current knowledge of the epidemiology and pathophysiology of these episodes, a |
|
|
|
|
|
| |